| Total | Acute kidney injury | Neurologic outcome at discharge | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
(−) | (+) | p-value | Good | Poor | p-value | |||||||
NGAL at ROSC | 124.0 | (96.0–186.0) | 105.5 | (83.3–143.3) | 142.0 | (107.0–263.0) | 0.001 | 105.0 | (84.0–141.0) | 140.0 | (140.6–245.8) | 0.002 |
NGAL at 3 h after ROSC | 181.0 | (115.0–381.0) | 115.0 | (84.3–145.5) | 353.0 | (223.0–510.0) | < 0.001 | 134.0 | (84.0–181.0) | 255.5 | (139.5–434.8) | < 0.001 |
CRRT | 11 | (14.7) | 0 | (0.0) | 11 | (23.4) | 0.005 | 1 | (3.6) | 10 | (23.1) | 0.045 |
CAG | 40 | (44.9) | 25 | (62.5) | 15 | (30.6) | 0.003 | 30 | (85.7) | 10 | (18.5) | < 0.001 |
Target temperature | Â | Â | Â | Â | Â | Â | 0.586 | Â | Â | Â | Â | 0.559 |
 33 °C | 86 | (96.6) | 38 | (95.0) | 48 | (98.0) |  | 33 | (94.3) | 53 | (98.1) |  |
 < 36 °C | 3 | (3.4) | 2 | (5.0) | 1 | (2.0) |  | 2 | (5.7) | 1 | (1.9) |  |
TTM duration | Â | Â | Â | Â | Â | Â | 0.624 | Â | Â | Â | Â | 1.000 |
 24 h | 85 | (95.5) | 39 | (97.5) | 46 | (93.9) |  | 34 | (97.1) | 51 | (94.4) |  |
 48 h | 4 | (4.5) | 1 | (2.5) | 3 | (6.1) |  | 1 | (2.9) | 3 | (5.6) |  |
Survival discharge | 48 | (53.9) | 34 | (85.0) | 14 | (28.6) | < 0.001 | 35 | (100.0) | 13 | (24.1) | < 0.001 |
CPC at discharge |  |  |  |  |  |  | < 0.001 |  |  |  |  |  |
 Good (1,2) | 35 | (39.3) | 26 | (65.0) | 9 | (18.4) |  |  |  |  |  |  |
 Poor (3,4,5) | 54 | (60.7) | 14 | (35.0) | 40 | (81.6) |  |  |  |  |  |  |
Survival at 1 month | 47 | (52.8) | 33 | (82.5) | 14 | (28.6) | < 0.001 | 35 | (100.0) | 12 | (22.2) | < 0.001 |
Survival at 6 months | 47 | (53.4) | 33 | (82.5) | 14 | (29.2) | < 0.001 | 35 | (100.0) | 12 | (22.6) | < 0.001 |